CLINICAL_TRIALS
trial_result
· 2023-05-25
Clinical Trial Update: Evaluation of N1539 Following Major Surgery [Phase 3]
Summary
Phase 3 clinical trial evaluating N1539 after major surgery has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baudax Bio | Conditions: Pain, Post-operative | Phase 3 | Status: COMPLETED | Results posted: 2023-05-25